Six
of Top 10 Pharmaceutical Companies Rely on Ariba for Spend Management
Leading manufacturer of healthcare products to share insights
and best practices for improving profits, reducing risk and driving
competitive advantage in October 19 webcast
SUNNYVALE, Calif. – October 10, 2006 – Six of the
top 10 pharmaceutical companies rely on Ariba®, Inc. (Nasdaq:
ARBA), the leading spend management solutions provider, to drive
their business objectives. On Thursday, October 19, Ariba will
host an interactive webcast during which one of the world’s
leading pharmaceutical companies will discuss how it is leveraging
Ariba’s offerings to improve profits, reduce supply risk
and gain competitive advantage. The live session will take place
from 11:00 a.m. – 12:00 p.m. ET.
"With increased competition from generic drugs, shrinking
R&D pipelines and a less favorable regulatory environment,
pharmaceutical companies around the world are facing significant
top-line revenue pressure," said Christopher Merchant, Director,
Strategic Sourcing, Ariba. "In order to remain profitable,
they must make spend management a priority."
Many pharmaceutical companies have already embraced
spend management and are leveraging Ariba’s unique combination
of technology, commodity expertise and services to drive their
goals, including:
Pfizer, Schering-Plough, Bristol Myers Squib, Amgen, Genzyme, Aventis
and AstraZeneca.
Spend management is a fast, efficient way to lower
total costs and raise the bottom line. Ariba’s webcasts
are uniquely designed to provide companies with access to practical,
actionable
information they can use to create and execute strategies that
deliver results.
For more information on the pharmaceutical webcast, or to register,
please visit:
http://www.scdigest.com/webinars/Spend_Management_06_10_19.cfm
Source : Ariba, Inc.
|